You are here

Article Text

Article menu

Download PDFPDF

Electronic pages
Correspondence
Let’s stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!
Free
  1. Maarten Boers
  1. Correspondence to Dr Maarten Boers Department of Epidemiology & Biostatistics, Amsterdam Rheumatology and Immunology Center, PO Box 7057, Amsterdam 1007 MB, The Netherlands; eb<at>vumc.nl

https://doi.org/10.1136/annrheumdis-2016-210063

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    I read with interest the report on the C-EARLY study.1 The study has been performed well, and the data support the conclusions. I do, however, take issue with the definition of the chosen endpoint of ‘sustained remission’, that is, a DAS28<2.6 at weeks 40 and 52. First, a period of 12 weeks is arbitrary and, in my view, rather short for a claim of ‘sustained remission’, but this is not my major worry. The new American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) remission criteria for rheumatoid arthritis …

    View Full Text

    Linked Articles